<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE nitf PUBLIC "-//IPTC//NITF DTD 3.0//EN" "nitf-3-0.dtd"><nitf baselang="EN-US"><head><meta content="CITE" name="_lnbillview"/><meta content="00001" name="_lnminrev"/><meta content="May 29, 2017" name="_eoptdate"/><meta content="20:14:46 EDT" name="_eopttime"/><meta content="DOCUMENT_TOKEN_PLACEHOLDER" name="documentToken"/><docdata><doc-id id-string="5NNG-MHX1-JB72-128F" regsrc="lexisnexis.com"/><date.issue norm="20170529T000000Z"/>2017-05-29</docdata><pubdata unit-of-measure="word" item-length="837" name=" PR Newswire Europe"/></head><body><body.head><hedline><hl1>Eisai and Charles River Laboratories Announce Extension of Integrated Drug Discovery Partnership</hl1></hedline></body.head><body.content/></body></nitf>